894
Views
8
CrossRef citations to date
0
Altmetric
Commentaries

Response to coronavirus 2019 in Veterans Health Administration facilities participating in an implementation initiative to enhance access to medication for opioid use disorder

, PT, DPT, PhDORCID Icon, , MD, MPH, FACP, DFASAMORCID Icon, , BAORCID Icon, , Pharm.D., BCPS, , MD, , PhD LP, MSPHORCID Icon & , PhDORCID Icon show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Daniel G. Parker, Daysi Zentner, Jacob A. Burack & Dennis C. Wendt. (2023) The impact of the COVID-19 pandemic on medications for opioid use disorder services in the U.S. and Canada: a scoping review. Drugs: Education, Prevention and Policy 30:6, pages 529-542.
Read now
Paul J. Joudrey, Gavin Bart, Robert K. Brooner, Lawrence Brown, Julie Dickson-Gomez, Adam Gordon, Sarah S. Kawasaki, Jane M. Liebschutz, Edward Nunes, Dennis McCarty, Robert P. Schwartz, José Szapocnik, Madhukar Trivedi, Judith I. Tsui, Arthur Williams, Li-Tzy Wu & David A. Fiellin. (2021) Research priorities for expanding access to methadone treatment for opioid use disorder in the United States: A National Institute on Drug Abuse Clinical Trials Network Task Force report. Substance Abuse 42:3, pages 245-254.
Read now

Articles from other publishers (6)

Aline M. Lott, Anissa N. Danner, Carol A. Malte, Emily C. Williams, Adam J. Gordon, Max A. Halvorson, Andrew J. Saxon, Hildi J. Hagedorn, George G. Sayre & Eric J. Hawkins. (2023) Clinician Perspectives on Delivering Medication Treatment for Opioid Use Disorder during the COVID-19 Pandemic: A Qualitative Evaluation. Journal of Addiction Medicine 17:4, pages e262-e268.
Crossref
Princess E. Ackland, Marie E. Kenny, Barbara A. Clothier, Hope A. Salameh, Natassia Boening, Adam J. Gordon, Siamak Noorbaloochi, Allison M. Gustavson, Wendy Miller & Hildi J. Hagedorn. (2023) What Contributes to Sustainability? Examining Access to Medications for Opioid Use Disorder in Low-Adopting VHA Facilities. Journal of General Internal Medicine.
Crossref
Bradley D. Stein, Rachel K. Landis, Flora Sheng, Brendan Saloner, Adam J. Gordon, Mark Sorbero & Andrew W. Dick. (2022) Buprenorphine Treatment Episodes During the First Year of COVID: a Retrospective Examination of Treatment Initiation and Retention. Journal of General Internal Medicine 38:3, pages 733-737.
Crossref
Nicholas A. Livingston, Michael Davenport, Michael Head, Rachel Henke, Lavonia Smith LeBeau, Teresa B. Gibson, Anne N. Banducci, Alexis Sarpong, Saketh Jayanthi, Clara Roth, Jessica Camacho-Cook, Frank Meng, Justeen Hyde, Norah Mulvaney-Day, Mackenzie White, Daniel C. Chen, Michael D. Stein & Risa Weisberg. (2022) The impact of COVID-19 and rapid policy exemptions expanding on access to medication for opioid use disorder (MOUD): A nationwide Veterans Health Administration cohort study. Drug and Alcohol Dependence 241, pages 109678.
Crossref
Ashley O. Radmall, Spencer Calder, Nodira Codell, Alan Taylor Kelley, Eric Hawkins, Audrey L. Jones, Hildi J. Hagedorn, Mary Anne Reynolds & Adam J. Gordon. (2022) Roles and Perceptions of Nurses During Implementation of a Medication Treatment for Opioid Use Disorder National Initiative. Journal of Addictions Nursing 33:2, pages 70-79.
Crossref
Adam J. Gordon, Marie Kenny, Matthew Dungan, Allison M. Gustavson, A. Taylor Kelley, Audrey L. Jones, Eric Hawkins, Joseph W. Frank, Anissa Danner, Joseph Liberto & Hildi Hagedorn. (2022) Are x‐waiver trainings enough? Facilitators and barriers to buprenorphine prescribing after x‐waiver trainings. The American Journal on Addictions 31:2, pages 152-158.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.